VASOGEN INC
Similar Organizations
Acambis plc
Acambis plc is a Biotechnology company.
ActiveCyte Inc.
ActiveCyte Inc. is a Biotechnology company.
Apex Bioscience
Apex Bioscience, Inc. is a biotechnology company
Aspire IRB
Aspire IRB is a BioTechnology Company.
Ciba Corning
Ciba Corning is a Biotechnology company.
Genesoft Inc.
Genesoft Inc. is a Biotechnology company.
Habgen, Inc.
Habgen, Inc. is a Biotechnology company.
Rhein biotech NV
Rhein biotech NV is a Biotechnology company.
T cell
T cell is a Biotechnology company.
More informations about "Vasogen Inc"
Vasogen Inc - Crunchbase Company Profile & Funding
Vasogen Inc is a Biotechnology company. There is no recent news or activity for this profile. Who are Vasogen Inc's competitors? Alternatives and possible competitors to Vasogen Inc may …See details»
Vasogen Inc - LinkedIn
Interested in working at Vasogen Inc? Vasogen Inc | 117 followers on LinkedIn.See details»
Vasogen Inc. and IntelliPharmaCeutics Jointly Announce
MISSISSAUGA, ON, Oct. 19 /CNW/ - Vasogen Inc. (NASDAQ:VSGN; TSX: VAS) and IntelliPharmaCeutics Ltd. ("IPC") are pleased to announce that shareholders of each company …See details»
Vasogen Inc., Mississauga, Ontario - CompanyListing.ca
Vasogen Inc Company Profile | Mississauga, ON, Canada
Find company research, competitor information, contact details & financial data for Vasogen Inc of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»
Vasogen and IntelliPharmaCeutics to Combine to Create Publicly …
Aug 19, 2009 · MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN; TSX:VAS) and IntelliPharmaCeutics (IPC) announced today that they have entered …See details»
Vasogen Inc - Drug pipelines, Patents, Clinical trials - Synapse
May 6, 2024 · Explore Vasogen Inc with its drug pipeline, therapeutic area, technology platform, 2 clinical trials.See details»
Vasogen and IntelliPharmaCeutics reach merger agreement
Aug 17, 2009 · Biotechnology company Vasogen inc (TSX: VAS, NASDAQ: VSGN) and private drug delivery innovator IntelliPharmaCeutics (IPC) today announced they’ve agreed to …See details»
BioPharmaLink profile of Vasogen Inc., Canada,
Vasogen Inc. is focused on the development and commercialization of immune modulation therapies to advance the treatment of cardiovascular, autoimmune and related inflammatory …See details»
Intellipharmaceutics and Vasogen Inc. Complete Arrangement to …
Oct 22, 2009 · The arrangement resulted in Intellipharmaceutics Ltd. and Intellipharmaceutics Corp. combining with 7231971 Canada Inc., a new Vasogen company, that acquired …See details»
Company - Cardiol Therapeutics
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease.See details»
Ailing Vasogen to merge with private firm - The Toronto Star
Aug 17, 2009 · Troubled biotechnology company Vasogen Inc. said Monday it has reached a deal to reorganized through an Alberta-based partnership and merge with a private pharmaceutical …See details»
David Elsley, MBA - Cardiol Therapeutics
In 1990, Mr. Elsley founded Vasogen Inc., a biotechnology company focused on the research and commercial development of novel therapeutics for the treatment of heart failure and other …See details»
VASOGEN INC : Vasogen Inc. and IntelliPharmaCeutics Jointly …
MISSISSAUGA, ON, Oct. 19 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) and IntelliPharmaCeutics Ltd. ("IPC") are pleased to announce that shareholders of each …See details»
Vasogen and IntelliPharmaCeutics to Combine to Create Publicly …
Vasogen Inc. announced that they have entered into a definitive agreement, subject to shareholder and regulatory approvals, whereby Vasogen will combine with IPC under a plan of …See details»
Chris Waddick, MBA, CPA, CMA - Cardiol Therapeutics
Mr. Waddick spent more than twelve years at Vasogen Inc., a biotechnology company focused on the research and commercial development of novel therapeutics for the treatment of heart …See details»
Vasogen Inc. - The New York Times
Vasogen Inc secures US patent for its bone marrow transplant cancer treatment; process involves treating T-cells in host's immune system in way that leaves them strong enough for graft to...See details»
VASOGEN INC : Vasogen and IntelliPharmaCeutics to Combine to …
MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) and IntelliPharmaCeutics (IPC) announced today that they have entered into a definitive …See details»
We Grow Vasculature
Vasogen’s easy-to-use Vascular Generation Platform enables academic and industrial researchers to conduct novel experiments exploring the biology of vascular networks, and …See details»
Vasogen and IntelliPharmaCeutics to Combine to Create
MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN - News; TSX:VAS - News) and IntelliPharmaCeutics (IPC) announced today that they have entered …See details»